← Back to Screener
ScreenerNewsCompareWatchlist
VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesNewsCompareWatchlist
AnalyzeValuationTotal ReturnDCA CalculatorInsider Activity
HomeStocksBIOARevenue History
OverviewPriceRevenueEarningsP/ERatiosDividendTargets

BIOA logoBioAge Labs, Inc. (BIOA) Revenue History

Annual and quarterly revenue from 2022 to 2025

TTM Revenue
$9.0M
0
YoY Growth
-
Latest Quarter
$3.1M
Q4 2025
QoQ Growth
+49.9%
Excellent

Compound Annual Growth Rate (CAGR)

3-Year-
5-Year-
10-Year-
Highest Annual Revenue$9.0M (2025)
Highest Quarter$3.1M (Q4 2025)
Revenue per Share$0.25
Revenue per Employee$145K

Loading revenue history...

BIOA Revenue Growth

1-Year Growth
-
3-Year CAGR
-
5-Year CAGR
-
10-Year CAGR
-
TTM vs Prior Year-
Revenue per Share$0.25
Revenue per Employee$145,080.645
Peak Annual Revenue$9.0M (2025)

Download Historical Data

4 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

BIOA Revenue Analysis (2022–2025)

As of May 8, 2026, BioAge Labs, Inc. (BIOA) generated trailing twelve-month (TTM) revenue of $9.0 million. The most recent quarter (Q4 2025) recorded $3.1 million in revenue, up 49.9% sequentially.

Looking at the longer-term picture, BIOA's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $9.0 million in 2025, representing a new all-time high.

When compared to Healthcare sector peers including KYMR (-12.6% YoY), LNTH (+0.6% YoY), and RYTM (+58.7% YoY). Compare BIOA vs KYMR →

BIOA Revenue vs Peers

Revenue metrics vs comparable public companies

CompanyTTM RevenueYoY Growth5Y CAGROp. MarginCompare
BIOA logoBIOACurrent$9M---1031.5%
KYMR logoKYMR$39M-12.6%+2.9%-891.3%
LNTH logoLNTH$1.5B+0.6%+35.3%20.2%
RYTM logoRYTM$190M+58.7%--101.2%
VNDA logoVNDA$216M+8.2%-2.7%-70.0%
Best in groupLowest in group

BIOA Historical Revenue Data (2022–2025)

Showing 4 of 4 records
Year Revenue YoY % Gross Profit Gross Margin Op. Income Op. Margin
2025$9.0M-$9.0M100.0%$-92,780,000-1031.5%
2024$0-$0-$-78,194,000-
2023$0-$0-$-48,400,000-
2022$0-$0-$-39,969,000-

See BIOA's True Return

Price is only half the story. See total return with reinvested dividends.

Launch Calculator

Is BIOA Undervalued?

DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.

View Valuation

Compare BIOA vs DBVT

Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..

Start Comparison

BIOA — Frequently Asked Questions

Quick answers to the most common questions about buying BIOA stock.

Is BIOA's revenue growth accelerating or slowing?

BIOA TTM revenue: $9M. YoY growth: N/A. 5-year CAGR: N/A.

What is BIOA's long-term revenue growth rate?

BioAge Labs, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.

How is BIOA's revenue distributed by segment?

BIOA reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2022-2025 are available for download. Segment mix reveals concentration and diversification trends.

VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screener
  • Themes
  • Market Valuation
  • Valuation
  • Compare
  • Total Return
  • DCA Calculator
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Follow @VCPScanner on X

Get weekly stock ideas — free

© 2026 VCP Scanner. All rights reserved.
About·Privacy Policy·Terms of Service
Not financial advice. Do your own research.

BIOA Revenue Over Time (2022–2025)